from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0686/-

LFCtreatmentdescriptionclass of inhibitor

-0.615

Amikacinug/mL Amikacintranslation

0.929

Cap5-10ug/mL Capreomycintranslation

1.211

Rox10-50 ug/mL Roxithromycintranslation

1.553

SM2-5 ug/mL Streptomycintranslation

-0.301

Tet5-10 ug/mL Tetracyclinetranslation

-0.476

Rif0.2-5ug/mL Rifampicintranscription

-0.149

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.234

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.876

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.053

CPZ10-50 ug/mL Chlorpromazinerespiration

0.211

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.495

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.264

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.100

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.037

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.067

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.102

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.146

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.193

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.910

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.606

KCN5-20 ug/mL Potassium cyaniderespiration

-1.060

NaN30.2-2 mM Sodium aziderespiration

1.280

Nigericin50 uM Nigericinrespiration

1.736

TRC10-150 ug/mL Triclosanrespiration

1.039

TRZ10-25 ug/mL Thioridazinerespiration

1.741

Valinomycin0.5-10 uM Valinomycinrespiration

-0.579

ZnSO42 mM ZnSO4respiration

0.138

menadione6-10 ug/mL Menadionerespiration

0.123

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.441

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.322

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.323

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.658

NRP_1Non-replicating persistence stage 1dosRassociated

0.139

Amp0.2mg/mL AmpicillincellWall

-0.369

Cephalexin20-100 ug/mL CephalexincellWall

-0.339

Cerulenin0.32-5 ug/mL CerulenincellWall

0.354

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.031

EMB10-20 ug/mL EthambutolcellWall

-0.753

Eta12-40 ug/mL EthionamidecellWall

-0.673

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.844

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.423

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.446

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.334

BZA0.12 mg/mL BenzamidearomaticAmides

1.034

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.479

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.324

H2O24 mM hydrogen peroxideDNAdamaging

-0.540

Levo10 ug/mL LevofloxacinDNAdamaging

0.224

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.429

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.512

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.442

UVUV-irradiationDNAdamaging

-0.071

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.747

Antimycin12.5-50 ug/mL Antimycin A?

-0.186

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.217

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.122

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.878

PA8240.2-2 ug/mL PA-824?

-0.645

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.524

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.095

Verapamil50 uM Verapamil?

-0.617

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.006

methoxatin10-20 ug/mL Methoxatin?